吉利德科学(GILD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GILD 吉利德科学

已收盘 11-06 16:00:00 EST

123.40

+0.82

+0.67%

盘后123.25

-0.15-0.12%

19:59 EST

最高124.10	最低121.72	成交量608.75万
今开121.93	昨收122.58	日振幅1.94%
总市值1,533亿	流通市值1,528亿	总股本12.42亿
成交额7.51亿	换手率0.49%	流通股本12.38亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GILD","market":"US","secType":"STK","nameCN":"吉利德科学","latestPrice":123.4,"timestamp":1762462800000,"preClose":122.58,"halted":0,"volume":6087471,"hourTrading":{"tag":"盘后","latestPrice":123.25,"preClose":123.4,"latestTime":"19:59 EST","volume":942594,"amount":116315230.8953,"timestamp":1762477193649},"delay":0,"floatShares":1238162880,"shares":1242000000,"eps":6.422841,"marketStatus":"已收盘","change":0.82,"latestTime":"11-06 16:00:00 EST","open":121.93,"high":124.1,"low":121.719,"amount":750713285.127195,"amplitude":0.019424,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":6.422841,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1762506000000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":696056400000,"exchange":"NASDAQ","adjPreClose":122.58,"dividendRate":0.025446,"preHourTrading":{"tag":"盘前","latestPrice":121.93,"preClose":122.58,"latestTime":"09:29 EST","volume":1268,"amount":154923.930608,"timestamp":1762439399999},"postHourTrading":{"tag":"盘后","latestPrice":123.25,"preClose":123.4,"latestTime":"19:59 EST","volume":942594,"amount":116315230.8953,"timestamp":1762477193649},"volumeRatio":0.732397,"optionData":{"bulkOrders":[{"symbol":"GILD","call":true,"expireDate":1763701200000,"strike":"122.0","timestamp":1762452189779,"price":3.6,"volume":1010,"amount":363600,"type":"-"}]},"impliedVol":0.2914,"impliedVolPercentile":0.26},"requestUrl":"/m/hq/s/GILD","defaultTab":"news","newsList":[{"id":"2581777998","title":"（第八届进博会）跨国药企深耕进博会 加速创新成果落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2581777998","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581777998?lang=zh_cn&edition=full","pubTime":"2025-11-05 22:40","pubTimestamp":1762353653,"startTime":"0","endTime":"0","summary":"中新社上海11月5日电(记者陈静)“过去七年，从展品到商品，再到临床广泛可及，进博会已成为创新药物加速惠及中国患者的重要催化平台。”诺华公司中国区副总裁，心血管、肾脏及代谢治疗领域兼创新患者服务负责人管宏5日对记者表示，得益于进博会的溢出效应，诺华公司多款心肾领域的创新药物实现首秀到落地的跨越。第八届中国国际进口博览会5日开幕。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511053556163538.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511053556163538.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1674673691.USD","PBC","LU1839511570.USD","BK4588","LU1571399168.USD","IE00B19Z3B42.SGD","SG9999015986.USD","06978","BK4568","SG9999015945.SGD","LU0109394709.USD","LU0234570918.USD","LU0114720955.EUR","IE00B7SZLL34.SGD","BK4139","IE00BSNM7G36.USD","BK4566","BK4578","IE00B3T34201.USD","LU0320765992.SGD","LU1066051498.USD","BK4550","LU1585245621.USD","LU2468319806.SGD","IE00BZ1G4Q59.USD","SG9999015978.USD","BK1161","IE00B19Z3581.USD","LU1066053197.SGD","BK4585","LU0889565916.HKD","LU2324357040.USD","LU2089984988.USD","BK4532","LU1674673428.USD","BK4583","LU1778281490.HKD","GILD","IE0002270589.USD","IE00BKVL7J92.USD","LU0289739699.SGD","LU0882574055.USD","BK1574","SG9999015952.SGD","LU2087621335.USD","LU0058720904.USD","LU1430594728.SGD","LU0823416689.USD"],"gpt_icon":0},{"id":"2581715385","title":"吉利德四赴进博会：全球首款长效HIV预防药亚洲首秀","url":"https://stock-news.laohu8.com/highlight/detail?id=2581715385","media":"南方都市报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581715385?lang=zh_cn&edition=full","pubTime":"2025-11-04 13:24","pubTimestamp":1762233852,"startTime":"0","endTime":"0","summary":"从“展品”到“药品”，从“首展”到“首用”，吉利德科学借进博会“黄金跑道”持续跑出“中国速度”。11月展台现场，吉利德将首次在亚洲公开展示这一全新的HIV预防方案，并同步披露其在全球同步研发框架下中国参与项目的最新进展——10项肿瘤、6项非肿瘤研究中，90%的肿瘤项目已实现与全球“零时差”开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104132704a6df8bb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104132704a6df8bb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1571399168.USD","SG9999015945.SGD","LU0058720904.USD","LU0234570918.USD","LU1674673691.USD","IE00BZ1G4Q59.USD","LU2087621335.USD","LU1674673428.USD","PBC","LU0289739699.SGD","LU0889565916.HKD","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","LU1066051498.USD","LU2468319806.SGD","BK4566","LU1066053197.SGD","BK4550","IE00B3T34201.USD","SG9999015952.SGD","SG9999015986.USD","LU1430594728.SGD","LU1585245621.USD","BK4532","LU2324357040.USD","LU0320765992.SGD","LU0109394709.USD","LU0114720955.EUR","IE00BKVL7J92.USD","BK4588","GILD","LU0882574055.USD","BK4583","SG9999015978.USD","BK4578","LU2089984988.USD","LU0823416689.USD","LU1839511570.USD","BK4585","IE0002270589.USD","IE00B19Z3581.USD","LU1778281490.HKD","BK4139","BK4568","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"1151483676","title":"吉利德与Kite在2025年ASH大会上展示血癌治疗新进展，发布新细胞疗法数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1151483676","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151483676?lang=zh_cn&edition=full","pubTime":"2025-11-03 22:11","pubTimestamp":1762179075,"startTime":"0","endTime":"0","summary":"吉利德与Kite在2025年ASH大会上展示血癌治疗新进展，发布新细胞疗法数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673691.USD","GILD","IE00B3T34201.USD","LU0320765992.SGD","LU2324357040.USD","BK4585","LU0889565916.HKD","SG9999015978.USD","BK4566","LU1585245621.USD","BK4550","IE00B19Z3581.USD","LU0882574055.USD","IE00B19Z3B42.SGD","LU2089984988.USD","IE00BSNM7G36.USD","BK4532","SG9999015986.USD","LU1066053197.SGD","IE0002270589.USD","BK4588","BK4578","BK4568","LU1066051498.USD","LU1571399168.USD","IE00BZ1G4Q59.USD","LU0289739699.SGD","LU0234570918.USD","LU0109394709.USD","BK4139","LU0114720955.EUR","IE00BKVL7J92.USD","LU1430594728.SGD","LU2468319806.SGD","LU1778281490.HKD","SG9999015952.SGD","LU2087621335.USD","IE00B7SZLL34.SGD","SG9999015945.SGD","LU1674673428.USD","LU0058720904.USD","LU0823416689.USD","BK4583","LU1839511570.USD"],"gpt_icon":0},{"id":"2580293352","title":"小摩上调吉利德科学目标价至150美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2580293352","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580293352?lang=zh_cn&edition=full","pubTime":"2025-11-03 17:40","pubTimestamp":1762162825,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00BSNM7G36.USD","LU2468319806.SGD","LU0889565916.HKD","LU1674673691.USD","BK4568","BK4578","BK4588","LU1066051498.USD","IE00B3T34201.USD","SG9999015986.USD","LU2087621335.USD","BK4566","GILD","LU1839511570.USD","LU1066053197.SGD","LU1430594728.SGD","LU0320765992.SGD","BK4139","BK4532","LU1674673428.USD","LU0882574055.USD","IE00B7SZLL34.SGD","BK4585","LU2324357040.USD","SG9999015978.USD","SG9999015945.SGD","LU0823416689.USD","IE0002270589.USD","SG9999015952.SGD","BK4550","LU0289739699.SGD","LU1571399168.USD","LU0058720904.USD","LU1778281490.HKD","IE00BZ1G4Q59.USD","LU0109394709.USD","LU0234570918.USD","BK4583","LU2089984988.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","LU0114720955.EUR","LU1585245621.USD"],"gpt_icon":0},{"id":"1199186581","title":"吉利德科学荣获2025年Prix Galien USA最佳药品奖，以Yeztugo®（Lenacapavir）获奖","url":"https://stock-news.laohu8.com/highlight/detail?id=1199186581","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199186581?lang=zh_cn&edition=full","pubTime":"2025-10-31 20:01","pubTimestamp":1761912113,"startTime":"0","endTime":"0","summary":"吉利德科学荣获2025年Prix Galien USA最佳药品奖，以Yeztugo®（Lenacapavir）获奖","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","LU2087621335.USD","LU0234570918.USD","BK4578","LU1066051498.USD","SG9999015945.SGD","LU0058720904.USD","LU2468319806.SGD","LU1571399168.USD","GILD","LU1066053197.SGD","BK4568","IE00B3T34201.USD","IE00BKVL7J92.USD","LU0889565916.HKD","SG9999015978.USD","LU0114720955.EUR","BK4550","LU1674673691.USD","BK4566","LU1839511570.USD","LU0823416689.USD","LU1430594728.SGD","LU0882574055.USD","SG9999015952.SGD","SG9999015986.USD","LU0320765992.SGD","LU2089984988.USD","BK4139","IE00BSNM7G36.USD","LU1674673428.USD","BK4588","IE0002270589.USD","BK4583","LU0289739699.SGD","IE00B19Z3B42.SGD","LU2324357040.USD","BK4532","LU1585245621.USD","IE00BZ1G4Q59.USD","LU1778281490.HKD","LU0109394709.USD","IE00B7SZLL34.SGD","BK4585"],"gpt_icon":0},{"id":"1125215408","title":"吉利德第三季调整后每股收益2.47美元，超出IBES预期的2.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1125215408","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125215408?lang=zh_cn&edition=full","pubTime":"2025-10-31 04:15","pubTimestamp":1761855301,"startTime":"0","endTime":"0","summary":"10月30日消息——吉利德第三季度产品销售额为73.45亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","LU1674673691.USD","LU1778281490.HKD","IE00B7SZLL34.SGD","IE00B19Z3B42.SGD","LU2324357040.USD","LU1585245621.USD","LU0109394709.USD","LU2087621335.USD","IE00BKVL7J92.USD","LU2089984988.USD","LU1066051498.USD","IE00BZ1G4Q59.USD","IE00B19Z3581.USD","BK4550","SG9999015952.SGD","SG9999015978.USD","IE00B3T34201.USD","LU1430594728.SGD","BK4139","SG9999015945.SGD","LU0234570918.USD","LU0289739699.SGD","LU1839511570.USD","IE00BSNM7G36.USD","LU1066053197.SGD","LU1674673428.USD","BK4566","LU0889565916.HKD","SG9999015986.USD","LU1571399168.USD","BK4568","BK4588","GILD","LU0114720955.EUR","LU0058720904.USD","BK4583","IE0002270589.USD","BK4585","LU0823416689.USD","BK4532","LU0320765992.SGD","LU0882574055.USD","BK4578"],"gpt_icon":0},{"id":"2579042541","title":"吉利德科学三季度营收77.7亿美元 高于市场预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2579042541","media":"蓝鲸财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579042541?lang=zh_cn&edition=full","pubTime":"2025-10-31 04:05","pubTimestamp":1761854744,"startTime":"0","endTime":"0","summary":"蓝鲸新闻10月31日电，吉利德科学三季度营收77.7亿美元，分析师预期74.6亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031040711a47e66c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031040711a47e66c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GILD"],"gpt_icon":0},{"id":"1166801343","title":"FDA批准吉利德科学的Yescarta用于治疗对一线化疗免疫疗法耐药的成人大B细胞淋巴瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=1166801343","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166801343?lang=zh_cn&edition=full","pubTime":"2025-10-28 23:04","pubTimestamp":1761663856,"startTime":"0","endTime":"0","summary":"FDA批准吉利德科学的Yescarta用于治疗对一线化疗免疫疗法耐药的成人大B细胞淋巴瘤","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1585245621.USD","LU1674673691.USD","BK4583","LU1066053197.SGD","IE00B19Z3581.USD","LU1778281490.HKD","LU0320765992.SGD","LU0114720955.EUR","IE00B19Z3B42.SGD","LU0889565916.HKD","BK4532","LU2324357040.USD","LU1066051498.USD","SG9999015945.SGD","LU1839511570.USD","IE00B3T34201.USD","LU0234570918.USD","LU0109394709.USD","LU0882574055.USD","LU1571399168.USD","IE00B7SZLL34.SGD","LU2089984988.USD","IE0002270589.USD","SG9999015986.USD","IE00BSNM7G36.USD","LU2468319806.SGD","LU1430594728.SGD","LU0289739699.SGD","LU0058720904.USD","BK4566","BK4568","GILD","BK4550","BK4588","LU0823416689.USD","SG9999015952.SGD","BK4578","IE00BZ1G4Q59.USD","SG9999015978.USD","IE00BKVL7J92.USD","LU2087621335.USD","LU1674673428.USD","BK4139","BK4585"],"gpt_icon":0},{"id":"2577307068","title":"跨国药企高层：进博会强大“溢出效应”成全球创新成果落地“加速器”","url":"https://stock-news.laohu8.com/highlight/detail?id=2577307068","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577307068?lang=zh_cn&edition=full","pubTime":"2025-10-23 21:06","pubTimestamp":1761224803,"startTime":"0","endTime":"0","summary":"中新网上海10月23日电(记者陈静)“进博会已成为全球新品首发、技术首秀和共享中国机遇的重要平台。过去连续三年参展，我们深切感受到进博会的‘溢出效应’，多款创新疗法通过‘进博快车’加速落地，更快惠及中国患者。”吉利德科学全球副总裁、中国区总经理金方千23日对记者表示。第八届中国国际进口博览会(简称：进博会)将要开幕，全球领先的生物制药企业吉利德科学将第四次亮相进博会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202510233542559744.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202510233542559744.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0889565916.HKD","BK4550","BK4585","IE00BSNM7G36.USD","LU1066053197.SGD","LU0289739699.SGD","LU0058720904.USD","LU0823416689.USD","GILD","IE00B19Z3581.USD","PBC","LU1066051498.USD","LU2324357040.USD","BK4583","LU0234570918.USD","LU0114720955.EUR","IE00B19Z3B42.SGD","SG9999015986.USD","SG9999015945.SGD","SG9999015978.USD","LU0320765992.SGD","BK4578","LU1585245621.USD","BK4588","LU2087621335.USD","LU0109394709.USD","BK4139","IE00B7SZLL34.SGD","LU1839511570.USD","IE00BKVL7J92.USD","BK4532","LU1674673691.USD","LU2089984988.USD","BK4566","BK4568","LU1778281490.HKD","LU1430594728.SGD","LU0882574055.USD","LU2468319806.SGD","IE0002270589.USD","IE00B3T34201.USD","SG9999015952.SGD","LU1571399168.USD","IE00BZ1G4Q59.USD","LU1674673428.USD"],"gpt_icon":0},{"id":"1163590253","title":"吉利德展示Livdelzi®（Seladelpar）在原发性胆汁性胆管炎（PBC）中的长期疗效阶段性数据以及针对慢性乙型肝炎的研究药物Bulevirtide","url":"https://stock-news.laohu8.com/highlight/detail?id=1163590253","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163590253?lang=zh_cn&edition=full","pubTime":"2025-10-23 20:00","pubTimestamp":1761220836,"startTime":"0","endTime":"0","summary":"吉利德展示Livdelzi®（Seladelpar）在原发性胆汁性胆管炎（PBC）中的长期疗效阶段性数据以及针对慢性乙型肝炎的研究药物Bulevirtide","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","LU1674673428.USD","BK4550","BK4578","IE00B19Z3B42.SGD","LU0320765992.SGD","LU2468319806.SGD","LU1778281490.HKD","LU0109394709.USD","BK4532","LU1066053197.SGD","SG9999015986.USD","BK4568","IE00BZ1G4Q59.USD","LU1674673691.USD","LU1571399168.USD","IE00BKVL7J92.USD","LU0114720955.EUR","LU0882574055.USD","LU1430594728.SGD","SG9999015945.SGD","LU0234570918.USD","BK4583","BK4588","GILD","LU0823416689.USD","LU0889565916.HKD","LU2087621335.USD","SG9999015952.SGD","IE00B3T34201.USD","IE0002270589.USD","BK4139","IE00B7SZLL34.SGD","LU2089984988.USD","BK4566","SG9999015978.USD","BK4585","LU1585245621.USD","LU2324357040.USD","LU1066051498.USD","IE00BSNM7G36.USD","LU1839511570.USD","LU0289739699.SGD","LU0058720904.USD"],"gpt_icon":0},{"id":"1185614039","title":"Lyvdelzi® (Seladelpar) 获得加拿大卫生部批准治疗原发性胆汁性胆管炎","url":"https://stock-news.laohu8.com/highlight/detail?id=1185614039","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185614039?lang=zh_cn&edition=full","pubTime":"2025-10-21 19:02","pubTimestamp":1761044558,"startTime":"0","endTime":"0","summary":"Lyvdelzi® (Seladelpar) 获得加拿大卫生部批准治疗原发性胆汁性胆管炎","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU1585245621.USD","LU2324357040.USD","LU1571399168.USD","BK4578","SG9999015952.SGD","BK4583","IE00B7SZLL34.SGD","IE00BKVL7J92.USD","SG9999015986.USD","LU1674673428.USD","BK4588","LU0058720904.USD","LU1778281490.HKD","LU0234570918.USD","LU1839511570.USD","LU0289739699.SGD","LU0882574055.USD","SG9999015945.SGD","BK4585","LU2089984988.USD","LU1066051498.USD","IE00B3T34201.USD","LU0109394709.USD","BK4550","LU1066053197.SGD","LU2468319806.SGD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","SG9999015978.USD","LU2087621335.USD","LU0320765992.SGD","LU0823416689.USD","BK4566","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","BK4568","LU1430594728.SGD","BK4139","LU1674673691.USD","LU0114720955.EUR","IE0002270589.USD","BK4532","GILD"],"gpt_icon":0},{"id":"1103856274","title":"Galapagos宣布终止其细胞疗法业务","url":"https://stock-news.laohu8.com/highlight/detail?id=1103856274","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103856274?lang=zh_cn&edition=full","pubTime":"2025-10-21 13:48","pubTimestamp":1761025693,"startTime":"0","endTime":"0","summary":"10月21日（路透社） - Galapagos NV：*GALAPAGOS宣布计划终止细胞疗法业务，作为公司持续转型的一部分*终止将影响全球365名员工*将关闭在荷兰、瑞士、美国和中国的多个基地*预计运营成本为1亿至1.25亿欧元，重组成本为1.5亿至2亿欧元*终止计划已获得Galapagos董事会批准，但不包括吉利德的董事*将于11月初与公司第三季度财报一起提供更新的2025年现金展望。 ((路透社投资简报；电子邮件：reutersinvestor.briefs@thomsonreuters.com))","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","BK4583","GILD","LU0823416689.USD","BK4566","BK4139","LU0882574055.USD","BK4568","SG9999015945.SGD","SG9999015952.SGD","LU0109394709.USD","LU1585245621.USD","LU2468319806.SGD","LU0320765992.SGD","LU1066053197.SGD","LU1430594728.SGD","IE00BKVL7J92.USD","IE00B3T34201.USD","LU0058720904.USD","BK4532","LU0234570918.USD","LU1571399168.USD","IE00B7SZLL34.SGD","IE00B19Z3B42.SGD","LU2087621335.USD","IE0002270589.USD","LU0114720955.EUR","BK4578","SG9999015986.USD","LU2324357040.USD","LU0889565916.HKD","IE00BSNM7G36.USD","SG9999015978.USD","LU1674673428.USD","LU1839511570.USD","BK4550","LU1066051498.USD","LU1778281490.HKD","BK4588","LU0289739699.SGD","LU1674673691.USD","BK4585","IE00BZ1G4Q59.USD","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"1169980172","title":"吉利德将在2025年IDWeek会议上重点展示HIV、病毒性肝炎和呼吸系统疾病的新病毒学数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1169980172","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169980172?lang=zh_cn&edition=full","pubTime":"2025-10-19 20:31","pubTimestamp":1760877079,"startTime":"0","endTime":"0","summary":"吉利德将在2025年IDWeek会议上重点展示HIV、病毒性肝炎和呼吸系统疾病的新病毒学数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU2468319806.SGD","IE00BZ1G4Q59.USD","BK4566","IE00BKVL7J92.USD","BK4583","LU0889565916.HKD","LU0320765992.SGD","LU0234570918.USD","LU1674673691.USD","IE00B19Z3581.USD","IE00B3T34201.USD","IE00BSNM7G36.USD","LU1430594728.SGD","BK4578","LU2087621335.USD","IE0002270589.USD","BK4532","LU1585245621.USD","LU1674673428.USD","BK4568","LU1778281490.HKD","BK4588","SG9999015986.USD","LU0823416689.USD","LU0289739699.SGD","LU2324357040.USD","BK4585","SG9999015952.SGD","GILD","LU0114720955.EUR","BK4550","LU1839511570.USD","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","LU1066053197.SGD","LU2089984988.USD","SG9999015978.USD","BK4139","LU1066051498.USD","SG9999015945.SGD","LU0109394709.USD","LU0882574055.USD","LU1571399168.USD"],"gpt_icon":0},{"id":"1195765083","title":"吉利德：Trodelvy在Ascent-03研究中对乳腺癌治疗与化疗相比降低38%的疾病进展或死亡风险","url":"https://stock-news.laohu8.com/highlight/detail?id=1195765083","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195765083?lang=zh_cn&edition=full","pubTime":"2025-10-19 14:30","pubTimestamp":1760855413,"startTime":"0","endTime":"0","summary":"吉利德：Trodelvy在Ascent-03研究中对乳腺癌治疗与化疗相比降低38%的疾病进展或死亡风险","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1839511570.USD","SG9999015978.USD","BK4585","IE00B19Z3B42.SGD","LU0234570918.USD","LU0289739699.SGD","BK4550","SG9999015986.USD","LU1430594728.SGD","LU2087621335.USD","IE00BZ1G4Q59.USD","BK4532","LU0882574055.USD","LU2324357040.USD","LU1674673691.USD","LU1778281490.HKD","LU0889565916.HKD","IE00B19Z3581.USD","IE00B7SZLL34.SGD","LU0109394709.USD","LU1066051498.USD","IE00BSNM7G36.USD","BK4583","SG9999015945.SGD","BK4578","LU1571399168.USD","LU2089984988.USD","LU1674673428.USD","BK4568","LU0114720955.EUR","LU0058720904.USD","LU0320765992.SGD","SG9999015952.SGD","GILD","IE00BKVL7J92.USD","LU1585245621.USD","LU2468319806.SGD","BK4139","LU1066053197.SGD","IE00B3T34201.USD","BK4566","IE0002270589.USD","LU0823416689.USD","BK4588"],"gpt_icon":0},{"id":"1108954329","title":"吉利德：在Ascent-03研究中，总体生存（OS）数据在无进展生存期（PFS）初步分析时尚不成熟，将继续监测OS结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1108954329","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108954329?lang=zh_cn&edition=full","pubTime":"2025-10-19 14:30","pubTimestamp":1760855413,"startTime":"0","endTime":"0","summary":"吉利德：在Ascent-03研究中，总体生存（OS）数据在无进展生存期（PFS）初步分析时尚不成熟，将继续监测OS结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZLL34.SGD","LU0114720955.EUR","LU1571399168.USD","IE00B19Z3581.USD","BK4532","LU0234570918.USD","SG9999015952.SGD","BK4578","LU1066051498.USD","BK4139","LU0889565916.HKD","LU1430594728.SGD","LU1674673428.USD","GILD","LU0320765992.SGD","IE00BSNM7G36.USD","BK4568","BK4566","IE00BKVL7J92.USD","LU0823416689.USD","BK4550","LU1066053197.SGD","IE00B19Z3B42.SGD","BK4588","SG9999015986.USD","LU0058720904.USD","LU0882574055.USD","SG9999015945.SGD","SG9999015978.USD","LU2324357040.USD","LU1585245621.USD","BK4583","LU2087621335.USD","BK4585","LU1778281490.HKD","LU1839511570.USD","LU0289739699.SGD","LU2089984988.USD","LU1674673691.USD","LU2468319806.SGD","LU0109394709.USD","IE0002270589.USD","IE00B3T34201.USD","IE00BZ1G4Q59.USD"],"gpt_icon":0},{"id":"1154562485","title":"吉利德：Ascent-03研究中，Trodelvy的中位无进展生存期为9.7个月，而化疗为6.9个月","url":"https://stock-news.laohu8.com/highlight/detail?id=1154562485","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154562485?lang=zh_cn&edition=full","pubTime":"2025-10-19 14:30","pubTimestamp":1760855413,"startTime":"0","endTime":"0","summary":"吉利德：在Ascent-03研究中，Trodelvy的中位无进展生存期为9.7个月，而化疗的中位无进展生存期为6.9个月。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU0058720904.USD","BK4583","SG9999015978.USD","IE00BKVL7J92.USD","IE0002270589.USD","BK4588","LU1674673691.USD","IE00B3T34201.USD","BK4139","BK4550","IE00BSNM7G36.USD","LU0320765992.SGD","LU1066053197.SGD","SG9999015952.SGD","GILD","LU2324357040.USD","LU0114720955.EUR","LU0882574055.USD","LU1674673428.USD","SG9999015986.USD","BK4566","LU1585245621.USD","LU2089984988.USD","IE00BZ1G4Q59.USD","BK4568","BK4578","SG9999015945.SGD","LU0289739699.SGD","LU1430594728.SGD","IE00B7SZLL34.SGD","LU1066051498.USD","LU2087621335.USD","BK4532","LU1839511570.USD","LU0109394709.USD","BK4585","LU2468319806.SGD","LU0234570918.USD","LU0889565916.HKD","LU1571399168.USD","LU0823416689.USD","LU1778281490.HKD"],"gpt_icon":0},{"id":"1153864676","title":"异动解读 | 吉利德科学盘中大涨5.23%，分析师看好艾滋病药物销售前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1153864676","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153864676?lang=zh_cn&edition=full","pubTime":"2025-10-18 01:32","pubTimestamp":1760722343,"startTime":"0","endTime":"0","summary":"今日盘中，生物制药公司吉利德科学股价大涨5.23%，引起市场广泛关注。据悉，这一涨幅主要受到分析师对公司核心产品销售预期的提振。加拿大皇家银行资本市场发布报告称，预计吉利德公司的艾滋病预防药物Yeztugo在第三季度的销售额将超过市场一致预期。此外，RBC还预计吉利德的另一款重磅艾滋病药物Biktarvy的第三季度销售额也将超出预期。值得注意的是，吉利德科学将于本月底公布第三季度财报，投资者对此充满期待。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GILD"],"gpt_icon":1},{"id":"1140292065","title":"吉利德科学在EACS 2025大会上发布HIV新研究数据——推动治疗和预防领域的科学创新","url":"https://stock-news.laohu8.com/highlight/detail?id=1140292065","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140292065?lang=zh_cn&edition=full","pubTime":"2025-10-15 15:30","pubTimestamp":1760513427,"startTime":"0","endTime":"0","summary":"吉利德科学在EACS 2025大会上发布HIV新研究数据——推动治疗和预防领域的科学创新","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","IE00B19Z3581.USD","LU1585245621.USD","BK4583","LU1839511570.USD","BK4588","LU1571399168.USD","BK4585","IE00BZ1G4Q59.USD","SG9999015986.USD","GILD","LU1674673691.USD","BK4568","IE00B19Z3B42.SGD","LU0289739699.SGD","IE00BKVL7J92.USD","LU0889565916.HKD","LU1674673428.USD","BK4139","LU0882574055.USD","LU0109394709.USD","LU2468319806.SGD","LU1066051498.USD","BK4550","IE00B7SZLL34.SGD","LU0320765992.SGD","LU2087621335.USD","BK4532","LU0823416689.USD","LU1430594728.SGD","IE00BSNM7G36.USD","SG9999015978.USD","IE0002270589.USD","BK4566","LU0234570918.USD","LU1778281490.HKD","IE00B3T34201.USD","LU2089984988.USD","LU1066053197.SGD","BK4578","LU0114720955.EUR","LU2324357040.USD","SG9999015952.SGD","SG9999015945.SGD"],"gpt_icon":0},{"id":"2574370441","title":"花旗上调吉利德科学目标价至135美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2574370441","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574370441?lang=zh_cn&edition=full","pubTime":"2025-10-09 17:39","pubTimestamp":1760002785,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0109394709.USD","LU0234570918.USD","BK4139","GILD","IE00B19Z3581.USD","LU2360032135.SGD","LU2456880835.USD","LU0052756011.USD","IE0002270589.USD","LU1778281490.HKD","IE00BKVL7J92.USD","LU2089984988.USD","IE00BSNM7G36.USD","LU0162691827.USD","LU0648001328.SGD","LU2087621335.USD","BK4532","IE00B3T34201.USD","LU0072461881.USD","LU0310800965.SGD","LU0320765646.SGD","LU0320765992.SGD","LU0128525689.USD","LU1585245621.USD","SG9999015945.SGD","BK4207","IE00BZ1G4Q59.USD","LU0170899867.USD","BK4550","BK4559","LU0106831901.USD","BK4566","LU1791807156.HKD","LU1201861249.SGD","LU0130102774.USD","LU1430594728.SGD","BK4504","LU1674673428.USD","LU0098860793.USD","LU0823416689.USD","BK4585","LU0289739699.SGD","LU0889565916.HKD","LU1162221912.USD","LU1267930227.SGD","BK4588","BK4568","LU1366192091.USD","LU2125154778.USD","LU0114720955.EUR"],"gpt_icon":0},{"id":"1104343854","title":"吉利德科学：预计第三季度收购在研项目支出将对GAAP和非GAAP每股收益造成约0.11美元的负面影响","url":"https://stock-news.laohu8.com/highlight/detail?id=1104343854","media":"美股速递","labels":["dataReport","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104343854?lang=zh_cn&edition=full","pubTime":"2025-10-08 04:26","pubTimestamp":1759868809,"startTime":"0","endTime":"0","summary":"吉利德科学表示，预计第三季度收购在研项目支出将对GAAP和非GAAP每股收益造成约0.11美元的负面影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1839511570.USD","SG9999015978.USD","BK4585","IE00B19Z3B42.SGD","LU0234570918.USD","LU0289739699.SGD","BK4550","SG9999015986.USD","LU1430594728.SGD","LU2087621335.USD","IE00BZ1G4Q59.USD","BK4532","LU0882574055.USD","LU2324357040.USD","LU1674673691.USD","LU1778281490.HKD","LU0889565916.HKD","IE00B19Z3581.USD","IE00B7SZLL34.SGD","LU0109394709.USD","LU1066051498.USD","IE00BSNM7G36.USD","BK4583","SG9999015945.SGD","BK4578","LU1571399168.USD","LU2089984988.USD","LU1674673428.USD","BK4568","LU0114720955.EUR","LU0058720904.USD","LU0320765992.SGD","SG9999015952.SGD","GILD","IE00BKVL7J92.USD","LU1585245621.USD","LU2468319806.SGD","BK4139","LU1066053197.SGD","IE00B3T34201.USD","BK4566","IE0002270589.USD","LU0823416689.USD","BK4588"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gilead.com","stockEarnings":[{"period":"1week","weight":0.0344},{"period":"1month","weight":0.0792},{"period":"3month","weight":0.1115},{"period":"6month","weight":0.2649},{"period":"1year","weight":0.3587},{"period":"ytd","weight":0.3271}],"compareEarnings":[{"period":"1week","weight":-0.0143},{"period":"1month","weight":0.0089},{"period":"3month","weight":0.0717},{"period":"6month","weight":0.2007},{"period":"1year","weight":0.1749},{"period":"ytd","weight":0.1561}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"吉利德科学公司于1987年6月22日在特拉华州成立，是一家以研究为基础的生物制药公司，致力于发现，开发和商业化未满足医疗需求的创新药物。该公司的主要重点领域包括病毒性疾病，炎性和纤维化疾病以及肿瘤学。","yearOnYearQuotes":[{"month":1,"riseRate":0.575758,"avgChangeRate":0.041534},{"month":2,"riseRate":0.411765,"avgChangeRate":0.007165},{"month":3,"riseRate":0.529412,"avgChangeRate":-0.009708},{"month":4,"riseRate":0.529412,"avgChangeRate":0.011973},{"month":5,"riseRate":0.558824,"avgChangeRate":0.0204},{"month":6,"riseRate":0.647059,"avgChangeRate":0.025673},{"month":7,"riseRate":0.558824,"avgChangeRate":0.01609},{"month":8,"riseRate":0.558824,"avgChangeRate":0.033158},{"month":9,"riseRate":0.558824,"avgChangeRate":0.031157},{"month":10,"riseRate":0.529412,"avgChangeRate":0.003173},{"month":11,"riseRate":0.647059,"avgChangeRate":0.038935},{"month":12,"riseRate":0.393939,"avgChangeRate":0.011167}],"exchange":"NASDAQ","name":"吉利德科学","nameEN":"Gilead Sciences"},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.5","shortVersion":"4.35.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"吉利德科学(GILD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供吉利德科学(GILD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"吉利德科学,GILD,吉利德科学股票,吉利德科学股票老虎,吉利德科学股票老虎国际,吉利德科学行情,吉利德科学股票行情,吉利德科学股价,吉利德科学股市,吉利德科学股票价格,吉利德科学股票交易,吉利德科学股票购买,吉利德科学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"吉利德科学(GILD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供吉利德科学(GILD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}